Neuralstem Receives FDA Approval To Commence Drug Trial For Major Depression
Links shared publicly online about this topic.
- 648total visits
Neuralstem Receives FDA Approval To Commence Drug Trial For Major Depression
Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test
View full resource at medicalnewstoday.com
Tags: Depression, Major Depression, Drug, FDA, Safety
Most Recently Shared on December 17, 2010 at 7:05 pm By:
Neuralstem Receives FDA Approval To Commence Drug Trial For Major Depression http://mnt.to/3Pff #clinicaltrials
Also Shared By:
Advertisement
MNT Depression News
@mnt_depression
Neuralstem Receives FDA Approval To Commence Drug Trial For Major Depression http://mnt.to/3Pff #depression
1 year ago...